The identification of BRCA1 and BRCA2 mutations is relevant for establishing preventive strategies for women with breast cancer and BRCA mutations, in order to prevent contralateral breast tumors and ovarian tumors. The gene discussed is BRCA1; the disease is ovarian neoplasm.